Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Axogen

Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted

Shares of Axogen plunged Monday after the FDA delayed the expected approval date for the company's nerve graft product.

Investors Business Daily

IBD Rating Upgrades: Axogen Shows Improved Price Strength

Axogen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Composite Rating For Axogen Jumps To 97

Axogen saw its IBD SmartSelect Composite Rating rise to 97 Friday, up from 94 the day before.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks With Rising Composite Ratings: Axogen

On Wednesday, Axogen got an upgrade for its IBD SmartSelect Composite Rating from 92 to 97.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga

Axogen: Q4 Earnings Insights

Axogen (NASDAQ:AXGN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen beat estimated earnings by 38.46%, reporting an EPS of $-0.08 versus an estimate of $-0.13.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

blockchain

1,333 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.